Sanctuary Advisors’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.19M Buy
74,269
+7,645
+11% +$329K 0.02% 718
2025
Q4
$2.92M Buy
66,624
+35,713
+116% +$1.48M 0.02% 739
2025
Q3
$1.28M Buy
30,911
+14,794
+92% +$595K 0.01% 1147
2025
Q2
$710K Sell
16,117
-20,808
-56% -$832K ﹤0.01% 1409
2025
Q1
$1.36M Sell
36,925
-34,519
-48% -$1.23M 0.01% 977
2024
Q4
$2.35M Buy
71,444
+32,183
+82% +$1.04M 0.01% 792
2024
Q3
$1.4M Buy
39,261
+11,757
+43% +$292K 0.01% 1081
2024
Q2
$652K Buy
+27,504
New +$610K ﹤0.01% 1458

Other funds holding EXEL

Sanctuary Advisors's EXEL Position: Q1 2026 in Review

Sanctuary Advisors increased its Exelixis (EXEL) stake by 11% in Q1 2026, buying an estimated $329K and bringing the position to 74,269 shares worth $3.19M. The position accounts for 0.02% of the portfolio, ranked #718.

Sanctuary Advisors first reported a position in EXEL in Q2 2024 and has held it in 8 quarters since. 694 funds tracked by Wall St. Rank hold EXEL as of Q1 2026.

  • Sanctuary Advisors held 74,269 shares of Exelixis worth $3.19M as of Q1 2026.
  • Sanctuary Advisors bought 7,645 Exelixis shares in Q1 2026, an estimated $329K.
  • Exelixis made up 0.02% of Sanctuary Advisors's portfolio in Q1 2026, its #718 holding.
  • Sanctuary Advisors first reported a position in Exelixis in Q2 2024 and has held it in 8 quarters since.
  • 694 funds tracked by Wall St. Rank held Exelixis as of Q1 2026.

Based on Sanctuary Advisors's 13F filing for Q1 2026, filed 5 May 2026.